ArticleAmerican journal of translational research2025

Re-challenge with immune checkpoint inhibitors as second-line treatment in advanced esophageal squamous cell carcinoma: a real-world multicenter retrospective study.

Peng Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.